Business
Admission to Trading & First Day of Dealings
Admission to Trading & First Day of Dealings.
About this update from Ondo Insur Tech Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 6719G\n Spinnaker Acquisitions PLC\n 28 July 2021\n \n \n \n \n Not for release or distribution, directly or indirectly, within, into or in the United States or to or for the account or benefit of persons in the United States, Australia, Canada, Japan or any other jurisdiction where such offer or sale would violate the relevant securities laws of such jurisdiction.\n \n \n \n \n \n 28th July 2021\n \n \n Spinnaker Acquisitions Plc\n \n \n (\"Company\" or \"Spinnaker\")\n \n \n Admission to Trading & First Day of Dealings\n \n \n Spinnaker Acquisitions plc, a company formed for the purpose of undertaking an acquisition or acquisitions of a majority interest in a company, business or asset, is pleased to announce that, following the publication of its Prospectus on 14 July 2021, a total of 22,110,060 ordinary shares will today be admitted to the standard segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc. \n \n \n Dealings will commence at 8:00 a.m. today under the TIDM SPAQ with ISIN number GB00BNVVGD77 and SEDOL BNVVGD7.\n \n \n \n \n \n Enquiries\n \n \n \n \n \n \n Spinnaker Acquisitions plc\n \n \n \n \n \n \n \n Andrew Morrison\n \n \n Non-Executive Chairman\n \n \n \n \n \n \n \n +44 7980 878561\n \n \n \n \n \n \n SI Capital Ltd\n \n \n (Company Broker)\n \n \n \n \n Nick Emerson\n \n \n Jon Levinson\n \n \n \n \n \n \n \n +44 (0) 1483 413 500\n \n \n +44 (0) 20 3143 0600\n \n \n \n \n \n \n Cassiopeia Services Ltd\n \n \n (PR & Investor Relations)\n \n \n \n \n Stefania Barbaglio\n \n \n \n \n +44 7949690338\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as pa...